MABDX, INC.
Medtech · Private
Point-of-care lateral flow assay for dengue diagnosis and severe dengue prognosis
- Grants
- $1000K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Agriculture · Diagnostic Tools For Managing Vibriosis In Marine Shellfish Hatcheries | $100,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel, Simple and Rapid Point-of-Care Lateral Flow Immunoassays for Diagnosis of Zika Virus Infection | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Simultaneous Diagnosis of Dengue and Prognosis of Severe Dengue with a Single Point-of-Care Test | $299,985 | |
| Federal grant | Department of Health and Human Services · Phase I · Simultaneous Diagnosis of Dengue and Prognosis of Severe Dengue with a Single Point-of-Care Test | $299,928 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1799 | LED RADIOFLUIDICS CORP | — | — |
| 1800 | EPIPHANY BIOSCIENCES, INC. | — | — |
| 1801 | CLEARNANO INC | — | — |
| 1802 | MABDX, INC. | — | — |
| 1803 | HEARTVISTA, INC. | — | — |
| 1804 | TF HEALTH CORPORATION | — | — |
| 1805 | AFFINERGY, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.